Literature DB >> 11252708

Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone.

V E Kimonis1, M J Kovach, B Waggoner, S Leal, A Salam, L Rimer, K Davis, R Khardori, D Gelber.   

Abstract

PURPOSE: To characterize the clinical features and perform linkage analysis of candidate loci in a large Illinois family with autosomal dominant limb-girdle muscular dystrophy (LGMD) and Paget disease of bone (PDB).
METHODS: The family includes 11 affected individuals (8 M, 3 F). Clinical, biochemical and radiologic evaluations were performed to delineate clinical features of the disorder. Linkage analysis with polymorphic markers was performed for previously identified LGMD, PDB and cardiomyopathy loci.
RESULTS: Onset of PDB is early, at a mean age of 35 y, with classic distribution involving the spine, pelvis, and skull. Muscle weakness and atrophy is progressive with mildly elevated to normal creatine phosphokinase levels. Muscle biopsy in the oldest male revealed vacuolated fibers, however, in others revealed nonspecific myopathy. Affected individuals die from progressive muscle weakness, and respiratory and cardiac failure in their 40s-60s. Linkage analysis excluded autosomal dominant and recessive LGMD, PDB, and cardiomyopathy loci.
CONCLUSION: Autosomal dominant LGMD associated with PDB is an unusual disorder. Linkage analysis indicates a unique locus in this family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11252708      PMCID: PMC6173187          DOI: 10.1097/00125817-200007000-00006

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  36 in total

1.  Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q.

Authors:  M C Speer; L H Yamaoka; J H Gilchrist; C P Gaskell; J M Stajich; J M Vance; A Kazantsev; A A Lastra; C S Haynes; J S Beckmann
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

2.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.

Authors:  A E Hughes; S H Ralston; J Marken; C Bell; H MacPherson; R G Wallace; W van Hul; M P Whyte; K Nakatsuka; L Hovy; D M Anderson
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

3.  Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD.

Authors:  M R Passos-Bueno; E S Moreira; M Vainzof; S K Marie; M Zatz
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

4.  A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization.

Authors:  W S Tucker; W H Hubbard; T D Stryker; S W Morgan; O B Evans; F R Freemon; G B Theil
Journal:  Trans Assoc Am Physicians       Date:  1982

5.  Computer-simulation methods in human linkage analysis.

Authors:  J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Osteitis deformans (Paget's disease) and calcific disease of the heart valves.

Authors:  H N Hultgren
Journal:  Am J Cardiol       Date:  1998-06-15       Impact factor: 2.778

7.  Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.

Authors:  L E Lim; F Duclos; O Broux; N Bourg; Y Sunada; V Allamand; J Meyer; I Richard; C Moomaw; C Slaughter
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

8.  Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Authors:  J R Mendell; J T Kissel; A A Amato; W King; L Signore; T W Prior; Z Sahenk; S Benson; P E McAndrew; R Rice
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

Review 9.  Steroids in muscular dystrophy: where do we stand?

Authors:  A L Dubrovsky; C Angelini; D M Bonifati; E Pegoraro; L Mesa
Journal:  Neuromuscul Disord       Date:  1998-08       Impact factor: 4.296

10.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.

Authors:  C Minetti; F Sotgia; C Bruno; P Scartezzini; P Broda; M Bado; E Masetti; M Mazzocco; A Egeo; M A Donati; D Volonte; F Galbiati; G Cordone; F D Bricarelli; M P Lisanti; F Zara
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

View more
  50 in total

1.  Global gene profiling of VCP-associated inclusion body myopathy.

Authors:  Angèle Nalbandian; Svetlana Ghimbovschi; Shlomit Radom-Aizik; Eric Dec; Jouni Vesa; Barbara Martin; Susan Knoblach; Charles Smith; Eric Hoffman; Virginia E Kimonis
Journal:  Clin Transl Sci       Date:  2012-04-04       Impact factor: 4.689

2.  In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Arianna Gomez; Naomi Walker; Hailing Su; Andrew Dunnigan; Marilyn Chwa; Jouni Vesa; M C Kenney; Virginia E Kimonis
Journal:  Mitochondrion       Date:  2015-02-25       Impact factor: 4.160

3.  The Myoblast C2C12 Transfected with Mutant Valosin-Containing Protein Exhibits Delayed Stress Granule Resolution on Oxidative Stress.

Authors:  Carlos J Rodriguez-Ortiz; Julio C Flores; Joanna A Valenzuela; Gema J Rodriguez; Joannee Zumkehr; Diana N Tran; Virginia E Kimonis; Masashi Kitazawa
Journal:  Am J Pathol       Date:  2016-04-20       Impact factor: 4.307

4.  Cooperative subunit dynamics modulate p97 function.

Authors:  Rui Huang; Zev A Ripstein; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-24       Impact factor: 11.205

5.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

6.  A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease.

Authors:  Michael A Gonzalez; Shawna M Feely; Fiorella Speziani; Alleene V Strickland; Matt Danzi; Chelsea Bacon; Youjin Lee; Tsui-Fen Chou; Susan H Blanton; Conrad C Weihl; Stephan Zuchner; Michael E Shy
Journal:  Brain       Date:  2014-08-14       Impact factor: 13.501

7.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

8.  A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation.

Authors:  Abhilasha Surampalli; Brian T Gold; Charles Smith; Rudy J Castellani; Manaswitha Khare; Hon Yu; Celeste Nguyen; Mary Lan; Marie Wencel; Sharon Wigal; Vince Caiozzo; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2014-10-22       Impact factor: 4.296

9.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

Review 10.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Authors:  Huabo Su; Xuejun Wang
Journal:  Cardiovasc Res       Date:  2009-08-20       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.